Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Nat Methods. 2013 Oct 13;10(12):1209–1210. doi: 10.1038/nmeth.2689

Figure 1. Druggability of genes recurrently mutated in breast cancer.

Figure 1

315 genes recurrently mutated in breast cancer patients were analyzed by DGIdb. A. The number of candidate breast cancer genes that are considered potentially druggable according to six sources. B. The numbers of genes in potentially druggable categories (from dGene) and the numbers of genes in these categories that are targeted by a known drug.